Home › Funds › CAPITAL COUNSEL LLC/NY › IONS

CAPITAL COUNSEL LLC/NY position in IONS

IONIS PHARMACEUTICALS INC · Health Care

CAPITAL COUNSEL LLC/NY reported holding 47,480 shares of IONS (IONIS PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.1M, representing 0.09% of its reported portfolio and ranking #25 among its reported holdings. CAPITAL COUNSEL LLC/NY has disclosed IONS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)47.48K sh
Reported value held$2.12M
Portfolio Weight0.09%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How CAPITAL COUNSEL LLC/NY's IONS position evolved

CAPITAL COUNSEL LLC/NY first disclosed a stake in IONS in Q3 2023 at 40,230 shares (US$1.8M). The position peaked in Q2 2026 at 49,580 shares, worth US$3.9M. Across 13 filings, CAPITAL COUNSEL LLC/NY increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 47,480 shares valued at US$2.1M — a reduction of -2,100 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2025 (shares rose 66% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 40.23K $1.82M New
Q4 2023 40.08K $2.03M Hold
Q1 2024 39.58K $1.72M Reduce
Q2 2024 37.08K $1.77M Reduce
Q3 2024 37.08K $1.49M Hold
Q4 2024 37.08K $1.30M Hold
Q1 2025 37.08K $1.12M Hold
Q2 2025 50.20K $1.98M Add
Q3 2025 49.60K $3.25M Reduce
Q4 2025 49.60K $3.92M Hold
Q1 2026 49.58K $3.72M Hold
Q2 2026 49.58K $3.93M Hold
Q3 2026 47.48K $2.12M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IONS and 13F data

IONS (IONIS PHARMACEUTICALS INC) is a Health Care company. 34 other funds we track also report a position in IONS — the largest reported positions include Two Sigma Investments (US$495.7M), TWO SIGMA ADVISERS, LP (US$241.5M), Deep Track Capital, LP (US$174.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IONS

All IONS fund holders →

FAQ

How long has CAPITAL COUNSEL LLC/NY held IONS?

CAPITAL COUNSEL LLC/NY has disclosed IONS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CAPITAL COUNSEL LLC/NY's current position in IONS?

As of Q3 2026, CAPITAL COUNSEL LLC/NY holds 47.48K shares of IONS (IONIS PHARMACEUTICALS INC), valued at $2.12M, representing 0.09% of its reported portfolio and ranking #25.

Has CAPITAL COUNSEL LLC/NY been buying or selling IONS?

In the latest 13F filing (Q3 2026), CAPITAL COUNSEL LLC/NY reduced its position in IONS. The position peaked in Q2 2026 at 49.58K shares.

Which other funds hold IONS?

Other major institutional holders of IONS include Two Sigma Investments, TWO SIGMA ADVISERS, LP, Deep Track Capital, LP, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.